title: Sildenafil citrate (VIAGRA): analysis of preferred doses in a European, six-month, double-blind, placebo-controlled, flexible dose-escalation study in patients with erectile dysfunction. Multicentre Study Group.
authors.affiliation: Hannover Medical School, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Hartmann
authors.forename: E J
authors.initials: EJ
authors.lastname: Meuleman
authors.forename: B
authors.initials: B
authors.lastname: Cuzin
authors.forename: H M
authors.initials: HM
authors.lastname: Emrich
authors.forename: G A
authors.initials: GA
authors.lastname: Declercq
authors.forename: M J
authors.initials: MJ
authors.lastname: Bailey
authors.forename: M C
authors.initials: MC
authors.lastname: Maytom
authors.forename: M D
authors.initials: MD
authors.lastname: Smith
authors.forename: I H
authors.initials: IH
authors.lastname: Osterloh
mesh_terms: D000293:Adolescent; D004311:Double-Blind Method; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate